# FDA Inspection 1210809 - Samuel N. Lederman, M.D. - July 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/samuel-n-lederman-md/ec43d1c5-a84c-4266-8aed-922eca20b586
Source feed: FDA_Inspections

> FDA Inspection 1210809 for Samuel N. Lederman, M.D. on July 21, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210809
- Company Name: Samuel N. Lederman, M.D.
- Inspection Date: 2023-07-21
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1076541 - 2019-01-11](https://www.keypedia.com/records/fda_inspections/samuel-n-lederman-md/09939dfc-ab21-4cbb-bdf9-dbed96f35711)
- [FDA Inspection 838148 - 2013-06-03](https://www.keypedia.com/records/fda_inspections/samuel-n-lederman-md/b2fb76e0-606e-4f15-904b-2524c08bad4e)

Company: https://www.keypedia.com/companies/samuel-n-lederman-md/42c54fb7-b989-4f3a-8bf9-e7a6caa075c5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c